• search

Biosyntech, Nicholas Piramal sign agreement

Written by: Staff

Mumbai, Nov 20: Canadian biotechnology company Biosyntech today signed a scientific collaboration agreement with its biopharmaceutical partner, Nicholas Piramal.

The collaboration involves clinical studies for BST-InPod, being developed to alleviate the chronic pain associated with foot fat pads.

Nicholas Piramal Strategic Alliances and Communications director Dr Swati Piramal told reporters after signing the MoU that the collaboration will help generate more clinical data at a lower cost in India. Nicholas Piramal holds 17 per cent equity stake in Biosyntech.

Chronic heel pain is widespread, and according to the American College of Foot and Ankle Surgeons, 14 per cent of the adult population suffer from it. Injected directly into the fat pad, BST-InPod is expected to result in long-term reduction in pain by improving the biomechanical function of the treated fat pad.

Later, while talking to sources, Dr Piramal said, ''We're looking for a perfect medicine for arthritis and the new medicine, which is likely to hit the market soon, will regenerate the cartilege in patient's body and help cure the chronic pain associated with foot-fat pads.'' She said the phase-II clinical trials for the development of drug will be conducted in both countries, India and Canada.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more